The inflammatory diseases rheumatoid arthritis (RA) and periodontitis show similarities in
misbalances of cytokine levels, such as tumor necrosis factor-α (TNF-α). RA has been …

Since the first reported use in 2001 of an anti–tumor necrosis factor-alpha (TNF-α) agent,
infliximab, for the treatment of uveitis, several new anti–TNF-α agents have emerged for the …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease - American Journal of
Cardiology Skip to Main Content The American Journal of Cardiology® Submit Log in Register …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 13th Annual Workshop on Advances in …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 10th Annual Workshop on Advances in …

Rheumatoid arthritis (RA) is a chronic autoimmune disorder and the treatment involves the
use of traditional and biological disease modifying anti-rheumatic drugs (DMARDs). Recent …

Rheumatoid arthritis (RA) is an autoimmune disease that, if untreated or poorly controlled,
can cause significant morbidity in terms of loss of physical function and higher mortality due …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 12th Annual Workshop on Advances in …